1. Search Result
Search Result
Isoforms Recommended: apoA1
Results for "

apo+a1

" in MedChemExpress (MCE) Product Catalog:

18

Inhibitors & Agonists

1

Biochemical Assay Reagents

1

Peptides

5

Recombinant Proteins

1

Antibodies

5

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-111540
    LY-3381916
    2 Publications Verification

    IDO1-IN-5

    Indoleamine 2,3-Dioxygenase (IDO) Cancer
    LY-3381916 (IDO1-IN-5) is a potent, selective and brain penetrated inhibitor of IDO1 activity, binds to apo-IDO1 lacking heme rather than mature heme-bound IDO1 [1].
    LY-3381916
  • HY-151123A

    AKCEA-APO(a)-LRx sodium; ISIS 681257 sodium; TQJ230 sodium

    Apolipoprotein DNA/RNA Synthesis Metabolic Disease
    Pelacarsen sodium (ISIS 681257 sodium) is a GalNAc3-conjugated 2′-MOE-modified antisense oligonucleotide. Pelacarsen sodium reduces apo (a) .
    Pelacarsen sodium
  • HY-151123

    AKCEA-APO(a)-LRx; ISIS 681257; TQJ230

    Apolipoprotein DNA/RNA Synthesis Metabolic Disease
    Pelacarsen (ISIS 681257) is a GalNAc3-conjugated 2′-MOE-modified antisense oligonucleotide. Pelacarsen reduces apo (a) .
    Pelacarsen
  • HY-111540B
    (S)-LY-3381916
    1 Publications Verification

    (S)-IDO1-IN-5

    Indoleamine 2,3-Dioxygenase (IDO) Cancer
    (S)-LY-3381916 ((S)-IDO1-IN-5; Example 1B) is an active S-isomer of LY-3381916. (S)-LY-3381916 binds to IDOL with an IC50 value less than 1.5 µΜ [1]. LY-3381916 is a potent, selective and brain penetrated inhibitor of Indoleamine 2,3-Dioxygenase 1 (IDO1) activity, binds to apo-IDO1 lacking heme rather than mature heme-bound IDO1 .
    (S)-LY-3381916
  • HY-165061

    Sciadonic acid

    Apolipoprotein Inflammation/Immunology
    5(Z),11(Z),14(Z)-Eicosatrienoic acid (Sciadonic acid), a polyunsaturated fatty acid sourced from maritime pine seed oil, gymnospermae leaves and seeds, and freshwater gastropods, has been shown to reduce high-density lipoprotein and ApoA1 levels in transgenic mice expressing human ApoA1 when included in their diet. In vitro studies indicate that it diminishes cholesterol efflux, and when applied topically in its methyl ester form, it alleviates inflammatory processes, likely by displacing arachidonic acid from phospholipid pools and lowering concentrations of downstream inflammatory mediators such as prostaglandin E2 and leukotrienes.
    5(Z),11(Z),14(Z)-Eicosatrienoic acid
  • HY-124187

    Ethyl pinolenate

    Biochemical Assay Reagents Others
    Pinolenic acid is a polyunsaturated fatty acid found in the seed oils of red pine (Pinus orientalis) and maritime pine (Pinus pinaster). Both oils were found to have lipid-lowering properties. A diet containing marine pine nut oil (MPSO) reduces HDL and ApoA1 levels in transgenic mice expressing human ApoA1. MPSO was found to reduce cholesterol efflux in vitro. Korean pine nut oil supplements may help obesity by reducing appetite. People who take this oil experience an increase in the satiety hormones CCK and GLP-1 and a decrease in appetite. The activity of the oil is attributed to pinolenic acid. Pinolenic acid is not metabolized to arachidonic acid and can reduce the level of arachidonic acid in the phosphatidylinositol fraction of HepG2 cells from 15.9% to 7.0%. Pinolenic acid ethyl ester is a neutral, more lipophilic form of the free acid.
    Pinolenic acid ethyl ester
  • HY-177784

    Molecular Glues Indoleamine 2,3-Dioxygenase (IDO) Infection Neurological Disease Cancer
    iDeg-3 is a selective molecular glue degrader that targets IDO1. iDeg-3 can competitively bind to the heme binding site of apo-IDO1, preventing heme binding and inhibiting the enzymatic reaction that converts tryptophan into kynurenine by IDO1 (IC50 = 46 nM). iDeg-3 can be used for the researches of cancer, infection and neurological disease, such as melanoma [1].
    iDeg-3
  • HY-13031

    Epigenetic Reader Domain Apolipoprotein Cancer
    GW 841819X is a potent inducer of the ApoA1 report gene, with an EC170 of 0.22 µM, and its pIC50 for Brd2/3/4 is 5.9/6.2/6.3 [1].
    GW 841819X
  • HY-178011

    Indoleamine 2,3-Dioxygenase (IDO) Cancer
    IDO1-IN-28 (Compound MQ-1) is a Apo-IDO1 inhibitor with an IC50 of 1.29  μM. IDO1-IN-28 selectively targets apo-IDO1 and disrupts heme binding. IDO1-IN-28 can be used for cancers research [1].
    IDO1-IN-28
  • HY-178024

    Indoleamine 2,3-Dioxygenase (IDO) Cancer
    IDO1-IN-29 (Compound MQ-1n) is a Apo-IDO1 inhibitor with an IC50 of 0.29  μM. IDO1-IN-29 selectively targets apo-IDO1 and disrupts heme binding. IDO1-IN-29 can be used for cancers research [1].
    IDO1-IN-29
  • HY-RS00829

    Small Interfering RNA (siRNA) Others

    APOA1 Human Pre-designed siRNA Set A contains three designed siRNAs for APOA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    APOA1 Human Pre-designed siRNA Set A
    APOA1 Human Pre-designed siRNA Set A
  • HY-177785

    Molecular Glues Indoleamine 2,3-Dioxygenase (IDO) Infection Neurological Disease Cancer
    iDeg-6 is a selective molecular glue degrader that targets IDO1 with a DC50 of 6.5 nM. iDeg-6 can competitively bind to the heme binding site of apo-IDO1, preventing heme binding and inhibiting the enzymatic reaction that converts tryptophan into kynurenine by IDO1 (IC50 = 1.6 μM). iDeg-6 can be used for the researches of cancer, infection and neurological disease, such as melanoma [1].
    iDeg-6
  • HY-RS17077

    Small Interfering RNA (siRNA) Others

    Apoa1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Apoa1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Apoa1 Mouse Pre-designed siRNA Set A
    Apoa1 Mouse Pre-designed siRNA Set A
  • HY-RS23521

    Small Interfering RNA (siRNA) Others

    Apoa1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Apoa1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Apoa1 Rat Pre-designed siRNA Set A
    Apoa1 Rat Pre-designed siRNA Set A
  • HY-172453

    Indoleamine 2,3-Dioxygenase (IDO) Cancer
    XW-032 is an apo-IDO1 inhibitor, with an IC50 of 21 nM. XW-032 (TGI = 63%) exhibits potent in vivo anti-tumor efficacy in the CT26 syngeneic mouse model and is expected to be applied in the research of the field of cancer [1].
    XW-032
  • HY-111540A

    (Rac)-IDO1-IN-5

    Indoleamine 2,3-Dioxygenase (IDO) Cancer
    (Rac)-LY-3381916 ((Rac)-IDO1-IN-5; Example 1) is a racemate of LY-3381916 [1]. LY-3381916 is a potent, selective and brain penetrated inhibitor of Indoleamine 2,3-Dioxygenase 1 (IDO1) activity, binds to apo-IDO1 lacking heme rather than mature heme-bound IDO1 .
    (Rac)-LY-3381916
  • HY-121698

    Cytochrome P450 Inflammation/Immunology
    GW694481 is an ApoA1 upregulator with IC50 values of 2.1 μM for CYP2C9 inhibition and 17.0 μM for CYP3A4 inhibition. GW694481 upregulates ApoA1 expression in human hepatic cells.GW694481 can be used for the research of atherosclerosis [1].
    GW694481
  • HY-181947

    Indoleamine 2,3-Dioxygenase (IDO) Cancer
    IDO1-IN-33 (Compound YC-16) is a IDO1 inhibitor (with an IC50 of 0.18 μM for IDO1 in HeLa cells). IDO1-IN-33 acts as an apo-IDO1 inhibitor by slowly and competitively displacing heme from mature holo-IDO1 and rapidly binding to the heme-binding site of immature apo-IDO1, without altering the expression level of IDO1. IDO1-IN-33 can be used for the research of hepatocellular carcinoma, non-small cell lung cancer, triple-negative breast cancer, and cervical cancer [1].
    IDO1-IN-33

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: